Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Chiesi
Pharma
After Amryt buy, Chiesi names Baxter vet Accogli its new CEO
A few weeks after acquiring rare disease specialist Amryt for $1.48 billion, Italy’s Chiesi Farmaceutici has named a new CEO, Giuseppe Accogli.
Kevin Dunleavy
Jan 30, 2023 2:00am
Chiesi supports painted hospitals project
Jun 3, 2022 9:00am
Chiesi study highlights economic burden of rare diseases
Mar 14, 2022 11:33am
Glaxo wins much-needed FDA nod for blockbuster prospect Trelegy
Sep 19, 2017 9:33am
Can other gene therapy developers avoid Glybera's fate?
May 4, 2016 10:55am